FIH Ph 1 Study of TRPC5 Channel Inhibitor GFB-887 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Double‐blind, randomized, placebo‐controlled, single‐dose, sequential‐group design in up to 7 cohorts of healthy participants.
Epistemonikos ID: ab9e3074274d5cb8ebe31cdd9c4623a313fbf942
First added on: May 22, 2024